Steroid Nasal Sprays Not Suitable For Rx-to-OTC Switch – Task Force
This article was originally published in The Tan Sheet
Executive Summary
The potential for consumers to overdose on intranasal corticosteroids without physician guidance makes the drug category inappropriate for Rx-to-OTC switch, a recent task force report finds